ARCHIVES

NCI-Approved Clinical Trials Listed For June 2001

This article is from The Cancer Letter archive.

Vol. 24 No. 7 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

RFPs Available

May 5, 2000

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS

January 24, 2014

In Brief: NCAB Vacancies Remained Unfilled; AHF’s 20thAnniversary To Be Celebrated In NY May 24

May 5, 1989

Millers, Jensen, Bereblum Win $100,000 GM awards

June 6, 1980

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003